Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy in allergic respiratory diseases.

D Vervloet1, X van der Brempt, D Charpin

  • 1Département des Maladies Respiratoires, Hôpital Sainte-Marguerite, Marseille, France.

Lung
|January 1, 1990
PubMed
Summary

Further research is required to define optimal immunotherapy indications for respiratory allergies. While effective for some, comparative studies on cost, risks, and efficacy against standard treatments are essential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiologic diagnosis of seasonal allergic rhinitis supported by artificial intelligence: The @IT-2020 project.

The Journal of allergy and clinical immunology·2026
Same author

Early Detection of Lower Adherence to Long-Term e-Diary Recording: A Checkpoint to Target Early Educational Intervention in Seasonal Allergic Rhinitis?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

[Wildfires and their respiratory impact].

Revue des maladies respiratoires·2025
Same author

Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries-The @IT.2020 multicenter study.

Allergy·2024
Same author

Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.

Pulmonology·2023
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Immunotherapy (IT) shows clinical efficacy in controlled studies for allergic rhinitis and asthma using pollen and mite extracts.
  • Current evidence is insufficient to establish the role of IT for allergies caused by animal danders and molds.
  • Comparative data on cost, risk factors, and efficacy of IT versus pharmacotherapy (antihistamines, bronchodilators, topical steroids) are lacking.

Purpose of the Study:

  • To highlight the need for further research to specify indications for immunotherapy in respiratory allergic diseases.
  • To identify critical questions that must be addressed before initiating immunotherapy for respiratory allergies.

Main Methods:

  • Review of existing controlled studies on immunotherapy for respiratory allergies.

Related Experiment Videos

  • Identification of knowledge gaps and areas requiring further investigation.

    • Main Results:

    • Pollen and mite immunotherapy demonstrate clinical efficacy compared to placebo in allergic rhinitis and/or asthma.
    • Significant need exists for controlled studies comparing immunotherapy with conventional treatments.
    • Further research is necessary to define immunotherapy's role in animal dander and mold allergies.

    Conclusions:

    • More research is needed to determine precise indications for immunotherapy in respiratory allergies.
    • Key factors such as allergen-symptom relationship, avoidance feasibility, drug treatment insufficiency, evidence of IT effectiveness, and patient compliance must be evaluated prior to IT initiation.